An investigation for shareholders in C R Bard Inc (NYSE:BCR) was announced over potential breaches of fiduciary duties by certain directors at C R Bard Inc. More specifically, the investigation concerns whether C.R. Bard potentially knew about fatal flaws associated with the G2 series filters they manufactured.